GDNF in treatment of Parkinson's disease: response to editorial.
Anthony E
AE
Lang
J William
JW
Langston
A Jon
AJ
Stoessl
Matthew
M
Brodsky
David J
DJ
Brooks
Vijay
V
Dhawan
William J
WJ
Elias
Andres M
AM
Lozano
Elena
E
Moro
John G
JG
Nutt
Mark
M
Stacy
Dennis
D
Turner
G Frederick
GF
Wooten
D002986:Clinical Trials as Topic; D051100:Glial Cell Line-Derived Neurotrophic Factor / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D028701:Patient Rights
D051100:Glial Cell Line-Derived Neurotrophic Factor